These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21624783)

  • 41. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting antibiotics to households for trachoma control.
    Blake IM; Burton MJ; Solomon AW; West SK; Basáñez MG; Gambhir M; Bailey RL; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e862. PubMed ID: 21072225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strategies to control trachoma.
    Mathew AA; Turner A; Taylor HR
    Drugs; 2009 May; 69(8):953-70. PubMed ID: 19496626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.
    Michel CE; Solomon AW; Magbanua JP; Massae PA; Huang L; Mosha J; West SK; Nadala EC; Bailey R; Wisniewski C; Mabey DC; Lee HH
    Lancet; 2006 May; 367(9522):1585-90. PubMed ID: 16698411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlamydia on children and flies after mass antibiotic treatment for trachoma.
    Lee S; Alemayehu W; Melese M; Lakew T; Lee D; Yi E; Cevallos V; Donnellan C; Zhou Z; Chidambaram JD; Gaynor BD; Whitcher JP; Lietman TM
    Am J Trop Med Hyg; 2007 Jan; 76(1):129-31. PubMed ID: 17255240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population-Based Prevalence of
    Nash SD; Astale T; Nute AW; Bethea D; Chernet A; Sata E; Zerihun M; Gessese D; Ayenew G; Ayele Z; Melak B; Haile M; Zeru T; Tadesse Z; Arnold BF; Callahan EK; Martin DL
    Am J Trop Med Hyg; 2021 Jan; 104(1):207-215. PubMed ID: 33200728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elimination of blinding trachoma.
    Schachter J; Dawson CR
    Curr Opin Infect Dis; 2002 Oct; 15(5):491-5. PubMed ID: 12686881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
    Rahman SA; West SK; Mkocha H; Munoz B; Porco TC; Keenan JD; Lietman TM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003682. PubMed ID: 25815466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trachoma: a review.
    Tabbara KF
    J Chemother; 2001 Apr; 13 Suppl 1():18-22. PubMed ID: 11434524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
    Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
    Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trachoma research: it takes more than a village.
    Lietman TM; Neuwelt MD; Gandhi NG; Dalmon CA; Benitah N
    Lancet; 2006 Feb; 367(9508):395. PubMed ID: 16458760
    [No Abstract]   [Full Text] [Related]  

  • 58. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
    Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
    Tilahun Z; Fenta TG
    BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
    House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
    Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.